Metformin Hydrochloride Extended-Release Tablets USP, 500 mg and 750 mg by Bayshore Pharmaceuticals

Recall of metformin hydrochloride extended-release tablets USP, 500 mg and 750 mg by Bayshore Pharmaceuticals due to N-Nitrosodimethylamine (NDMA).

More on the FDA website .

Alert covering recent metformin extended-release recalls.